ADAM17 and cancer: A recent finding indicated that iNOS-synthesized NO displayed a distinctive feature of cancer stem cells (CSCs) which exhibited self-renewal capacity, and iNOS/NO could promote Notch1 activation via TACE/ADAM17 signal way in liver cancer stem cells (LCSCs), finally resulting in a more aggressive tumor phenotype [22].